Description:
Kalorama Information’s Histology and Cytology IVD Market Update report provides a comprehensive competitive analysis of the histology/cytology market from 2021 to 2026. Histology and cytology are crucial components of pathological labs, delivering vital information about cells, tissues, and organs, which are essential for diagnosing various diseases. Physicians depend heavily on these analyses for making informed decisions regarding cancer and other diseases, thereby shaping treatment plans and prognoses.
Key Insights:
- Market Analysis: Detailed examination of market trends, with forecasts extending to 2026.
- Technological Advancements: Insights into how advancements in digital imaging, quantitative microscopy, precision microscopy, artificial intelligence, and virtual histology are revolutionizing the industry.
- Segment Analysis: The market is segmented into five key areas:
- Traditional Non-PAP Stains
- PAP
- In Situ Hybridization
- Immunohistochemistry
- HPV
Featuring:
- Market Data: All market data pertains to the world market at the manufacturers’ level. The base year for data is 2021, with data projections provided for 2026, including compound annual growth rates (CAGRs) for the period.
- Regional Analysis: Market breakdowns for the United States, Europe, Asia-Pacific, and the Rest of the World.
- Analysis of market growth driven by demographic trends, new developments, innovative technology, and global expansion.
Competitive Landscape:
- Profiles and competitive analysis of five key market participants:
- Agilent
- Danaher
- Hologic
- Illumina
- Roche
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global Histology/Cytology Sales, by Type, 2021-2026 (in millions $)
Type | IVD Sales 2021 | % Mkt | IVD Sales 2026 | % Mkt | CAGR % |
Pap tests | $XX Million | XX% | $XX Million | XX% | XX% |
in situ hybridization | $XX Million | XX% | $XX Million | XX% | XX% |
immunohistochemistry | $XX Million | XX% | $XX Million | XX% | XX% |
traditional non-Pap stains | $XX Million | XX% | $XX Million | XX% | XX% |
HPV – DNA | $XX Million | XX% | $XX Million | XX% | XX% |
TOTAL | $XX Million | XX% | $XX Million | XX% | XX% |
Source: Kalorama Information